Literature DB >> 18709346

[Therapy-induced effects in normal tissue].

G van Kaick1, S Delorme.   

Abstract

More than 50% of cancer patients survive for more than 5 years, owing to modern and effective treatment. Therefore, long-term sequelae of treatment are more frequently seen than in the past. Such effects on normal tissue may both mimic and obscure tumor recurrences. Besides the direct consequences of surgery, tissue damage due to radiation or chemotherapy frequently cause problems in differential diagnosis. Among the numerous sequelae of radiotherapy, the most prominent are disturbance of the blood-brain barrier, radiation pneumonitis, osteodystrophy and osteoradionecrosis, fatty changes of bone marrow, or increased radiodensity of breast parenchyma. Chemotherapy may cause, e.g., diffuse abnormalities of white matter, pneumonitis and lung fibrosis, cardiomyopathy, or diffuse and patchy changes in bone marrow signals in MRI. The most devastating long-term complications are secondary cancers and leukemia induced by both radiotherapy and chemotherapy.

Entities:  

Mesh:

Year:  2008        PMID: 18709346     DOI: 10.1007/s00117-008-1729-3

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  10 in total

1.  [Bone marrow changes following radiotherapy. Results of MR tomography].

Authors:  H U Kauczor; B Dietl; K F Kreitner; G Brix
Journal:  Radiologe       Date:  1992-10       Impact factor: 0.635

2.  [Stereotactic radiation therapy for liver metastases].

Authors:  K K Herfarth; J Debus
Journal:  Chirurg       Date:  2005-06       Impact factor: 0.955

Review 3.  Positron emission tomography for radiation treatment planning.

Authors:  Anca-Ligia Grosu; Morand Piert; Wolfgang A Weber; Branislav Jeremic; Maria Picchio; Ulrich Schratzenstaller; Frank B Zimmermann; Markus Schwaiger; Michael Molls
Journal:  Strahlenther Onkol       Date:  2005-08       Impact factor: 3.621

Review 4.  The epidemiology of second primary cancers.

Authors:  Lois B Travis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-10-20       Impact factor: 4.254

5.  Fatty replacement of bone marrow after radiation therapy for Hodgkin disease: quantification with chemical shift imaging.

Authors:  H U Kauczor; B Dieti; G Brix; K Jarosch; M V Knopp; G van Kaick
Journal:  J Magn Reson Imaging       Date:  1993 Jul-Aug       Impact factor: 4.813

6.  Bone marrow after autologous blood stem cell transplantation and total body irradiation: magnetic resonance and chemical shift imaging.

Authors:  H U Kauczor; G Brix; B Dietl; K Jarosch; M V Knopp; G van Kaick
Journal:  Magn Reson Imaging       Date:  1993       Impact factor: 2.546

7.  Radiation effects on breast cancer risk: a pooled analysis of eight cohorts.

Authors:  Dale L Preston; Anders Mattsson; Erik Holmberg; Roy Shore; Nancy G Hildreth; John D Boice
Journal:  Radiat Res       Date:  2002-08       Impact factor: 2.841

8.  Recurrent rectal cancer: diagnosis with dynamic MR imaging.

Authors:  M Müller-Schimpfle; G Brix; G Layer; P Schlag; R Engenhart; S Frohmuller; T Hess; I Zuna; W Semmler; G van Kaick
Journal:  Radiology       Date:  1993-12       Impact factor: 11.105

Review 9.  Cancer chemotherapy I: hepatocellular injury.

Authors:  Edmundo A Rodriguez-Frias; William M Lee
Journal:  Clin Liver Dis       Date:  2007-08       Impact factor: 6.126

10.  Relationship of leukemia risk to radiation dose following cancer of the uterine corpus.

Authors:  R E Curtis; J D Boice; M Stovall; L Bernstein; E Holowaty; S Karjalainen; F Langmark; P C Nasca; A G Schwartz; M J Schymura
Journal:  J Natl Cancer Inst       Date:  1994-09-07       Impact factor: 13.506

  10 in total
  4 in total

1.  A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089.

Authors:  Khushboo Sharma; Rachel W Goehe; Xu Di; Mark Anthony Hicks; Suzy V Torti; Frank M Torti; Hisashi Harada; David A Gewirtz
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

Review 2.  [The medical management of high risk individuals. Experiences with persons exposed to chronic internal irradiation].

Authors:  G van Kaick; S Delorme
Journal:  Radiologe       Date:  2011-12       Impact factor: 0.635

Review 3.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update.

Authors:  Da-Zhi Liu; Bradley P Ander
Journal:  ScientificWorldJournal       Date:  2012-04-01

4.  Etiology and treatment of osteonecrosis of the mandible.

Authors:  Florian Bast; Andreas Groß; Lars Hecht; Thomas Schrom
Journal:  Contemp Oncol (Pozn)       Date:  2013-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.